Market revenue in 2023 | USD 45.7 million |
Market revenue in 2030 | USD 70.8 million |
Growth rate | 6.5% (CAGR from 2023 to 2030) |
Largest segment | Transbronchial needle aspiration (tbna) needles |
Fastest growing segment | Transbronchial Needle Aspiration (TBNA) Needles |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Biopsy Forceps, Transbronchial Needle Aspiration (TBNA) Needles, Cytology Brushes |
Key market players worldwide | Olympus Corp, Boston Scientific Corp, Conmed Corp, Medtronic PLC, Becton Dickinson & Co, Hobbs Medical, Cook Medical, Telemed Systems, Argon Medical Devices, Horizons International |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to bronchial biopsy devices market will help companies and investors design strategic landscapes.
Transbronchial needle aspiration (tbna) needles was the largest segment with a revenue share of 67.61% in 2023. Horizon Databook has segmented the China bronchial biopsy devices market based on biopsy forceps, transbronchial needle aspiration (tbna) needles, cytology brushes covering the revenue growth of each sub-segment from 2018 to 2030.
The bronchial biopsy devices market in China is a rapidly expanding sector within the country's healthcare industry, driven by significant investments in healthcare infrastructure, increasing prevalence of respiratory diseases, and advancements in medical technology.
The prevalence of respiratory diseases, including COPD and lung cancer, is increasing in China due to high smoking rates, urban air pollution, and industrial emissions. According to recent data from the China National Cancer Center, lung cancer is the most common cancer and a leading cause of cancer-related deaths in China.
This growing disease burden is expected to drive the demand for effective diagnostic tools, including bronchial biopsy devices. Moreover, China is heavily investing in its healthcare sector as part of its broader strategy to improve medical services and infrastructure. The government’s “Healthy China 2030” initiative aims to enhance healthcare delivery and support the integration of advanced medical technologies.
Horizon Databook provides a detailed overview of country-level data and insights on the China bronchial biopsy devices market , including forecasts for subscribers. This country databook contains high-level insights into China bronchial biopsy devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account